Phototherapy: a promising treatment option for skin sclerosis in scleroderma?

C Sunderkötter, A Kuhn, N Hunzelmann… - Rheumatology, 2006 - academic.oup.com
In systemic sclerosis (SSc; scleroderma) fibrosis of the skin can lead to considerable
morbidity. No significant improvement has been reported from studies investigating …

Extracorporeal photopheresis: clinical use so far

KW Sanford, RA Balogun - Journal of Clinical Apheresis, 2012 - Wiley Online Library
Extracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis
procedure in which blood is separated into its various components and the isolated buffy …

Recent advances in phototherapy

JC Simon, D Pfieger, E Schöpf - European Journal of Dermatology, 2000 - jle.com
This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …

Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis

S Topuzoglu, R Knobler, O Movadat… - Photodermatology …, 2015 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) improves skin sclerosis in systemic
sclerosis (SS c) patients. SSc is associated with an increased risk of lung cancer. As ECP is …

Extracorporeal photopheresis in dermatology

L Pérez-Carmona, A Harto-Castaño… - Actas Dermo …, 2009 - Elsevier
Extracorporeal photochemotherapy or photopheresis is an immunomodulatory therapy that
combines leukapheresis with phototherapy. Blood from the patient is processed to give a …

[HTML][HTML] Extracorporeal photochemotherapy does not suppress T-or B-cell responses to novel or recall antigens

KR Suchin, M Cassin, R Washko, G Nahass… - Journal of the American …, 1999 - Elsevier
Background: Extracorporeal photopheresis (ExP) is an effective therapy for several
conditions including cutaneous T-cell lymphoma, scleroderma, and allograft rejection …

Extracorporeal photopheresis: what is it and when should it be used?

J Scarisbrick - Clinical and experimental dermatology, 2009 - academic.oup.com
Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …

Photopheresis: current and future perspectives

EC Vonderheid - Journal of Cutaneous Medicine and Surgery …, 2003 - Springer
Extracorporeal photopheresis (ECP), also known as extracorporeal photochemotherapy or
photoimmunotherapy, is the brainchild of Richard Edelson, MD, currently Professor and …

Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis

G Papp, IF Horvath, S Barath, E Gyimesi, J Vegh… - Clinical …, 2012 - Elsevier
The aim of this study was to evaluate the clinical and immunomodulatory effects of
extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 …

Extracorporeal Photopheresis in Dermatological Diseases

H Terhaar, M Saleem, N Yusuf - International Journal of Molecular …, 2024 - mdpi.com
Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used
as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as …